Use of activated prothrombin complex concentrate in a severely hemophilic patient with factor VIII inhibitor

W. J. Garehime, B. C. Pecaro, D. Green

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The successful use of an activated PCC in combination with a fibrinolytic agent in a patient with severe hemophilia and inhibitor to Factor VIII has been described. Activated prothrombin complex concentrate effected rapid hemostasis, and no complication occurred. In comparison with other materials currently used to achieve hemostasis in such patients, this concentrate appears to be safer and more effective, if properly administered.

Original languageEnglish (US)
Pages (from-to)262-264
Number of pages3
JournalJournal of Oral and Maxillofacial Surgery
Volume41
Issue number4
DOIs
StatePublished - Apr 1983

ASJC Scopus subject areas

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Use of activated prothrombin complex concentrate in a severely hemophilic patient with factor VIII inhibitor'. Together they form a unique fingerprint.

Cite this